Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion type Assertion NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_head.
- NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_provenance.
- NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion evidence source_evidence_literature NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_provenance.
- NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion SIO_000772 14578204 NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_provenance.
- NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion wasDerivedFrom befree-20140225 NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_provenance.
- NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_assertion wasGeneratedBy ECO_0000203 NP789826.RAhurTdAkoc5B5r2HpDMdbpd6A8mNIMvtqjloE1bArTWg130_provenance.